Search Results - "Osorio, Yaneth E"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Transcriptional Profiling in Experimental Visceral Leishmaniasis Reveals a Broad Splenic Inflammatory Environment that Conditions Macrophages toward a Disease-Promoting Phenotype by Kong, Fanping, Saldarriaga, Omar A, Spratt, Heidi, Osorio, E Yaneth, Travi, Bruno L, Luxon, Bruce A, Melby, Peter C

    Published in PLoS pathogens (01-01-2017)
    “…Visceral Leishmaniasis (VL), caused by the intracellular protozoan Leishmania donovani, is characterized by relentlessly increasing visceral parasite…”
    Get full text
    Journal Article
  2. 2
  3. 3

    In-situ proliferation contributes to the accumulation of myeloid cells in the spleen during progressive experimental visceral leishmaniasis by Osorio, E Yaneth, Medina-Colorado, Audrie A, Travi, Bruno L, Melby, Peter C

    Published in PloS one (12-11-2020)
    “…Visceral leishmaniasis (VL) is characterized by expansion of myeloid cells in the liver and spleen, which leads to a severe splenomegaly associated with higher…”
    Get full text
    Journal Article
  4. 4

    Inflammatory stimuli alter bone marrow composition and compromise bone health in the malnourished host by Osorio, E. Yaneth, Gugala, Zbigniew, Patterson, Grace T., Palacios, Genesis, Cordova, Erika, Uscanga-Palomeque, Ashanti, Travi, Bruno L., Melby, Peter C.

    Published in Frontiers in immunology (02-08-2022)
    “…Inflammation has a role in the pathogenesis of childhood malnutrition. We investigated the effect of malnutrition and inflammatory challenge on bone marrow…”
    Get full text
    Journal Article
  5. 5

    A secondary wave of neutrophil infiltration causes necrosis and ulceration in lesions of experimental American cutaneous leishmaniasis by Peniche, Alex G, Bonilla, Diana L, Palma, Gloria I, Melby, Peter C, Travi, Bruno L, Osorio, E Yaneth

    Published in PloS one (07-06-2017)
    “…We evaluated the importance of neutrophils in the development of chronic lesions caused by L. Viannia spp. using the hamster as experimental model of American…”
    Get full text
    Journal Article
  6. 6

    Efficacy of histamine H1 receptor antagonists azelastine and fexofenadine against cutaneous Leishmania major infection by Peniche, Alex G, Osorio, E Yaneth, Melby, Peter C, Travi, Bruno L

    Published in PLoS neglected tropical diseases (01-08-2020)
    “…Current drug therapies for cutaneous leishmaniasis are often difficult to administer and treatment failure is an increasingly common occurrence. The efficacy…”
    Get full text
    Journal Article
  7. 7

    Growth factor and Th2 cytokine signaling pathways converge at STAT6 to promote arginase expression in progressive experimental visceral leishmaniasis by Osorio, E Yaneth, Travi, Bruno L, da Cruz, Alda M, Saldarriaga, Omar A, Medina, Audrie A, Melby, Peter C

    Published in PLoS pathogens (01-06-2014)
    “…Host arginase 1 (arg1) expression is a significant contributor to the pathogenesis of progressive visceral leishmaniasis (VL), a neglected tropical disease…”
    Get full text
    Journal Article
  8. 8

    Double Staining with Fluorescent Tracers to Determine Myeloid Cell Migration of Leishmania -infected Cells from Mouse Skin to Lymphatic Tissues by Flow Cytometry by Uscanga-Palomeque, Ashanti C, Osorio, Yaneth E, Melby, Peter C

    Published in Bio-protocol (20-09-2023)
    “…Immune cell trafficking in steady-state conditions and inflammatory cell recruitment into injured tissues is crucial for the surveillance of the immune system…”
    Get full text
    Journal Article
  9. 9

    Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression by Osorio, E Yaneth, Zhao, Weiguo, Espitia, Claudia, Saldarriaga, Omar, Hawel, Leo, Byus, Craig V, Travi, Bruno L, Melby, Peter C

    Published in PLoS pathogens (01-01-2012)
    “…The clinicopathological features of the hamster model of visceral leishmaniasis (VL) closely mimic active human disease. Studies in humans and hamsters…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14

    Growth Factor and Th2 Cytokine Signaling Pathways Converge at STAT6 to Promote Arginase Expression in Progressive Experimental Visceral Leishmaniasis: e1004165 by Osorio, E Yaneth, Travi, Bruno L, Cruz, Alda Mda, Saldarriaga, Omar A, Medina, Audrie A, Melby, Peter C

    Published in PLoS pathogens (01-06-2014)
    “…Host arginase 1 (arg1) expression is a significant contributor to the pathogenesis of progressive visceral leishmaniasis (VL), a neglected tropical disease…”
    Get full text
    Journal Article
  15. 15
  16. 16

    An ex vivo splenic explant model system for the identification of small molecule therapeutics for visceral leishmaniasis by Osorio, Yaneth E., Travi, Bruno L., Melby, Peter C.

    Published in The FASEB journal (01-03-2008)
    “…Abstract only New therapies for leishmaniasis are needed. We established an ex vivo splenic explant culture system from hamsters infected with…”
    Get full text
    Journal Article
  17. 17

    Dominant arginase expression in a model of progressive visceral leishmaniasis by Osorio, Yaneth E., Zhao, Weiguo, Espitia, Claudia, Travi, Bruno L., Hawel, Leo, Byus, Craig V., Saldarriaga, Omar A., Melby, Peter C.

    Published in The FASEB journal (01-03-2008)
    “…Abstract only Progressive disease in the hamster model of visceral leishmaniasis (VL), caused by Leishmania donovani, mimics human VL. During progressive…”
    Get full text
    Journal Article